A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Clinical trial NCT07260110 · RECRUITING

Trial details

NCT number: NCT07260110
Sponsor: Sanofi
Status: RECRUITING
Study type: OBSERVATIONAL

Type 1 Diabetes

Start date: 2025-10-31
Primary completion: 2030-12-03
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.